• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种源自MA2020的更高效的CRISPR-Cas12a变体。

A more efficient CRISPR-Cas12a variant derived from MA2020.

作者信息

Tran Mai H, Park Hajeung, Nobles Christopher L, Karunadharma Pabalu, Pan Li, Zhong Guocai, Wang Haimin, He Wenhui, Ou Tianling, Crynen Gogce, Sheptack Kelly, Stiskin Ian, Mou Huihui, Farzan Michael

机构信息

Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL 33458, USA.

X-ray Crystallography Core, The Scripps Research Institute, Jupiter, FL 33458, USA.

出版信息

Mol Ther Nucleic Acids. 2021 Feb 18;24:40-53. doi: 10.1016/j.omtn.2021.02.012. eCollection 2021 Jun 4.

DOI:10.1016/j.omtn.2021.02.012
PMID:33738137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7940699/
Abstract

CRISPR effector proteins introduce double-stranded breaks into the mammalian genome, facilitating gene editing by non-homologous end-joining or homology-directed repair. Unlike the more commonly studied Cas9, the CRISPR effector protein Cas12a/Cpf1 recognizes a T-rich protospacer adjacent motif (PAM) and can process its own CRISPR RNA (crRNA) array, simplifying the use of multiple guide RNAs. We observed that the Cas12a ortholog of MA2020 (Lb2Cas12a) edited mammalian genes with efficiencies comparable to those of AsCas12a and LbCas12a. Compared to these well-characterized Cas12a orthologs, Lb2Cas12a is smaller and recognizes a narrow set of PAM TTTV. We introduced two mutations into Lb2Cas12a, Q571K and C1003Y, that increased its cleavage efficiency for a range of target sequences beyond those of the commonly used Cas12a orthologs AsCas12a and LbCas12a. In addition to the canonical TTTV PAM, this variant, Lb2-KY, also efficiently cleaved target regions with CTTN PAMs. Finally, we demonstrated that Lb2-KY ribonucleoprotein (RNP) complexes edited two hemoglobin target regions useful for correcting common forms of sickle-cell anemia more efficiently than commercial AsCas12a RNP complexes. Thus, Lb2-KY has distinctive properties useful for modifying a range of clinically relevant targets in the human genome.

摘要

CRISPR效应蛋白会在哺乳动物基因组中引入双链断裂,通过非同源末端连接或同源定向修复促进基因编辑。与更常被研究的Cas9不同,CRISPR效应蛋白Cas12a/Cpf1识别富含T的原间隔相邻基序(PAM),并能加工自身的CRISPR RNA(crRNA)阵列,从而简化了多个引导RNA的使用。我们观察到MA2020的Cas12a直系同源物(Lb2Cas12a)编辑哺乳动物基因的效率与AsCas12a和LbCas12a相当。与这些特征明确的Cas12a直系同源物相比,Lb2Cas12a更小,并且识别一组狭窄的PAM TTTV。我们在Lb2Cas12a中引入了两个突变,即Q571K和C1003Y,这提高了它对一系列靶序列的切割效率——超出了常用的Cas12a直系同源物AsCas12a和LbCas12a的切割效率范围。除了典型的TTTV PAM外,这个变体Lb2-KY还能有效切割具有CTTN PAM的靶区域。最后,我们证明,Lb2-KY核糖核蛋白(RNP)复合物编辑两个对纠正常见形式的镰状细胞贫血有用的血红蛋白靶区域,比商业化的AsCas12a RNP复合物更有效。因此,Lb2-KY具有独特的特性,有助于修饰人类基因组中一系列临床相关的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/8cf4a77479e9/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/18d610546dc0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/70f96ed9c1e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/736bb70de22a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/44da0a64a61d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/c2cc5ae61011/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/ef03dba5d9e7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/8cf4a77479e9/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/18d610546dc0/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/70f96ed9c1e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/736bb70de22a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/44da0a64a61d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/c2cc5ae61011/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/ef03dba5d9e7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68be/7940699/8cf4a77479e9/gr6.jpg

相似文献

1
A more efficient CRISPR-Cas12a variant derived from MA2020.一种源自MA2020的更高效的CRISPR-Cas12a变体。
Mol Ther Nucleic Acids. 2021 Feb 18;24:40-53. doi: 10.1016/j.omtn.2021.02.012. eCollection 2021 Jun 4.
2
Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity.工程化 Cas12a-Plus 核酸酶可提高基因编辑的活性和特异性。
BMC Biol. 2022 Apr 25;20(1):91. doi: 10.1186/s12915-022-01296-1.
3
Highly Efficient Genome Editing in Plant Protoplasts by Ribonucleoprotein Delivery of CRISPR-Cas12a Nucleases.通过CRISPR-Cas12a核酸酶的核糖核蛋白递送在植物原生质体中进行高效基因组编辑
Front Genome Ed. 2022 Jan 31;4:780238. doi: 10.3389/fgeed.2022.780238. eCollection 2022.
4
Cas12a variants designed for lower genome-wide off-target effect through stringent PAM recognition.通过严格的 PAM 识别设计的 Cas12a 变体,降低全基因组脱靶效应。
Mol Ther. 2022 Jan 5;30(1):244-255. doi: 10.1016/j.ymthe.2021.10.010. Epub 2021 Oct 20.
5
CRISPR/Cas12a Mediated Genome Editing Enhances Resistance to BmNPV.CRISPR/Cas12a介导的基因组编辑增强对家蚕核型多角体病毒的抗性
Front Bioeng Biotechnol. 2020 Jul 15;8:841. doi: 10.3389/fbioe.2020.00841. eCollection 2020.
6
Comparison of CRISPR-Cas9/Cas12a Ribonucleoprotein Complexes for Genome Editing Efficiency in the Rice Phytoene Desaturase (OsPDS) Gene.用于水稻八氢番茄红素去饱和酶(OsPDS)基因基因组编辑效率的CRISPR-Cas9/Cas12a核糖核蛋白复合物比较
Rice (N Y). 2020 Jan 21;13(1):4. doi: 10.1186/s12284-019-0365-z.
7
Comparison of Cas12a and Cas9-mediated mutagenesis in tomato cells.番茄细胞中 Cas12a 和 Cas9 介导的突变比较。
Sci Rep. 2024 Feb 24;14(1):4508. doi: 10.1038/s41598-024-55088-4.
8
Structures of apo Cas12a and its complex with crRNA and DNA reveal the dynamics of ternary complex formation and target DNA cleavage.apo Cas12a 及其与 crRNA 和 DNA 的复合物的结构揭示了三元复合物形成和靶 DNA 切割的动力学。
PLoS Biol. 2023 Mar 14;21(3):e3002023. doi: 10.1371/journal.pbio.3002023. eCollection 2023 Mar.
9
New PAM Improves the Single-Base Specificity of crRNA-Guided LbCas12a Nuclease.新型PAM提高了crRNA引导的LbCas12a核酸酶的单碱基特异性。
Life (Basel). 2022 Nov 18;12(11):1927. doi: 10.3390/life12111927.
10
A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing.一种具有严格 PAM 识别特性的 Cas12a 同源物,随后是基因组编辑的低脱靶编辑率。
Genome Biol. 2020 Mar 25;21(1):78. doi: 10.1186/s13059-020-01989-2.

引用本文的文献

1
Genetic engineering of bacteriophage S16 for Salmonella separation, concentration, and detection.用于沙门氏菌分离、浓缩和检测的噬菌体S16基因工程
Anal Bioanal Chem. 2025 May 27. doi: 10.1007/s00216-025-05924-x.
2
Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies.杜氏肌营养不良症的基因编辑:从实验模型到新兴疗法
Degener Neurol Neuromuscul Dis. 2025 Apr 12;15:17-40. doi: 10.2147/DNND.S495536. eCollection 2025.
3
Highly parallel profiling of the activities and specificities of Cas12a variants in human cells.

本文引用的文献

1
Novel Type V-A CRISPR Effectors Are Active Nucleases with Expanded Targeting Capabilities.新型 V-A CRISPR 效应物是具有扩展靶向能力的活性核酸酶。
CRISPR J. 2020 Dec;3(6):454-461. doi: 10.1089/crispr.2020.0043. Epub 2020 Nov 3.
2
The Diversity of Genetic Outcomes from CRISPR/Cas Gene Editing is Regulated by the Length of the Symmetrical Donor DNA Template.CRISPR/Cas 基因编辑的遗传结果多样性受对称供体 DNA 模板长度的调控。
Genes (Basel). 2020 Sep 30;11(10):1160. doi: 10.3390/genes11101160.
3
Mechanism of Dynamic Binding of Replication Protein A to ssDNA.
人类细胞中Cas12a变体活性和特异性的高度平行分析。
Nat Commun. 2025 Mar 28;16(1):3022. doi: 10.1038/s41467-025-57150-9.
4
Engineering of CRISPR-Cas PAM recognition using deep learning of vast evolutionary data.利用大量进化数据的深度学习对CRISPR-Cas PAM识别进行工程设计。
bioRxiv. 2025 Jan 6:2025.01.06.631536. doi: 10.1101/2025.01.06.631536.
5
A resurrected ancestor of Cas12a expands target access and substrate recognition for nucleic acid editing and detection.Cas12a的一个复活祖先扩展了用于核酸编辑和检测的靶点范围及底物识别能力。
Nat Biotechnol. 2024 Oct 31. doi: 10.1038/s41587-024-02461-3.
6
CRISPR technology in human diseases.用于人类疾病治疗的CRISPR技术。
MedComm (2020). 2024 Jul 29;5(8):e672. doi: 10.1002/mco2.672. eCollection 2024 Aug.
7
Mn-induced structural flexibility enhances the entire catalytic cycle and the cleavage of mismatches in prokaryotic argonaute proteins.锰诱导的结构灵活性增强了原核生物 Argonaute 蛋白的整个催化循环及错配切割。
Chem Sci. 2024 Mar 14;15(15):5612-5626. doi: 10.1039/d3sc06221j. eCollection 2024 Apr 17.
8
Optimization of Nuclear Localization Signal Composition Improves CRISPR-Cas12a Editing Rates in Human Primary Cells.核定位信号组成的优化提高了人类原代细胞中的CRISPR-Cas12a编辑率。
GEN Biotechnol. 2022 Jun;1(3):271-284. doi: 10.1089/genbio.2022.0003. Epub 2022 Jun 14.
9
are emerging industrial biocatalysts and biotherapeutics.正在涌现的工业生物催化剂和生物治疗药物。
Front Bioeng Biotechnol. 2024 Jan 4;11:1324396. doi: 10.3389/fbioe.2023.1324396. eCollection 2023.
10
CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain high expression in human hematopoietic iPSC-derived lineages and primary cells.基因组安全位点中整合了CRISPR-Cas12a的转基因在人造血诱导多能干细胞衍生谱系和原代细胞中保持高表达。
iScience. 2023 Oct 27;26(12):108287. doi: 10.1016/j.isci.2023.108287. eCollection 2023 Dec 15.
复制蛋白 A 与 ssDNA 动态结合的机制。
J Chem Inf Model. 2020 Oct 26;60(10):5057-5069. doi: 10.1021/acs.jcim.0c00564. Epub 2020 Oct 9.
4
CRISPR-Cas12a exploits R-loop asymmetry to form double-strand breaks.CRISPR-Cas12a 通过利用 R 环不对称性形成双链断裂。
Elife. 2020 Jun 10;9:e55143. doi: 10.7554/eLife.55143.
5
Characterization of Cas12a nucleases reveals diverse PAM profiles between closely-related orthologs.Cas12a 核酸酶的特性分析揭示了密切相关的同源物之间多样化的 PAM 特征。
Nucleic Acids Res. 2020 Jun 4;48(10):5624-5638. doi: 10.1093/nar/gkaa272.
6
A Cas12a ortholog with stringent PAM recognition followed by low off-target editing rates for genome editing.一种具有严格 PAM 识别特性的 Cas12a 同源物,随后是基因组编辑的低脱靶编辑率。
Genome Biol. 2020 Mar 25;21(1):78. doi: 10.1186/s13059-020-01989-2.
7
Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.CRISPR-Cas 系统的进化分类:Class 2 及其衍生变体的爆发。
Nat Rev Microbiol. 2020 Feb;18(2):67-83. doi: 10.1038/s41579-019-0299-x. Epub 2019 Dec 19.
8
Synthetic chimeric nucleases function for efficient genome editing.人工合成嵌合核酸酶可高效进行基因组编辑。
Nat Commun. 2019 Dec 4;10(1):5524. doi: 10.1038/s41467-019-13500-y.
9
A Survey of Genome Editing Activity for 16 Cas12a Orthologs.16 种 Cas12a 同源物的基因组编辑活性研究综述
Keio J Med. 2020 Sep 25;69(3):59-65. doi: 10.2302/kjm.2019-0009-OA. Epub 2019 Nov 14.
10
Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates.在非人类灵长类动物中,经 CRISPR-Cas9 编辑的富含造血干细胞的群体的治疗相关植入以及 HbF 再激活。
Sci Transl Med. 2019 Jul 31;11(503). doi: 10.1126/scitranslmed.aaw3768.